Paul Nghiem, MD, PhD, FAAD
SESSIONS
S026 Late-breaking Research: Session 1
Mar 9, 2024
•
9:00 AM - 12:00 PM
•
Room 20B
S050 Late-Breaking Research: Session 2
Mar 10, 2024
•
1:00 PM - 4:00 PM
•
Room 20B
DISCLOSURES
Almirall – Consultant(Honoraria); Bristol-Myers Squibb – Investigator(Grants/Research Funding); EMD Serono – Consultant(Fees); Merck & Co., Inc – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria);